体外式膜酸素供給装置の市場：モダリティ、年齢、コンポーネント、用途、エンドユーザー別-2024-2030年の世界予測

体外式膜酸素供給装置市場規模は2023年に7億9,486万米ドルと推定され、2024年には8億3,214万米ドルに達し、CAGR 4.55%で2030年には10億8,563万米ドルに達すると予測されています。

体外式膜酸素供給装置は、心臓や肺が生命を維持するのに十分なガス交換を行うことができない患者に、長時間の心臓・呼吸器サポートを提供する医療機器です。これらの機械は、患者の体内から血液を取り出し、人工肺（膜）を通して酸素を供給し、二酸化炭素を除去した後、患者の血流に戻します。この外部生命維持システムは、心臓と肺の機能を代行し、重篤な病気の間、これらの臓器を休ませ回復させる。心血管疾患や呼吸器疾患の急増と、患者の予後を改善する技術の進歩により、ECMOシステムの採用が増加しています。さらに、ヘルスケア・インフラの改善と医療費の増加が市場拡大に寄与しています。ECMO処置に関連する高額な費用と、これらの機械を操作する訓練を受けた医療専門家の数が限られていることが、市場成長の課題となっています。とはいえ、携帯性を高め、さまざまな治療環境での使いやすさを向上させるECMO装置の設計の進歩は、市場に好機をもたらすと期待されています。さらに、ECMOはその他の体外療法と統合され、ECMOサポートの適応拡大に焦点を当てた調査活動が市場を押し上げると予想されます。

モダリティ心臓と呼吸の両方をサポートする静脈動脈ECMOの利用が増加

動静脈式体外膜酸素療法（AV ECMO）は、患者の動脈血流と静脈血流を利用してECMO回路内の血液を駆動する、ECMOサポートの古い方法です。AV ECMOでは、血液は動脈から吸引され、酸素化後に静脈に戻されます。この手技は、酸素供給器を通して血液を送り出す患者の心臓に依存しています。最近のECMO療法では、技術の進歩により効率と安全性の点で他の方式が好まれるようになったため、あまり使用されなくなった。静脈動脈体外膜酸素化療法（VA ECMO）は、静脈血液を回収し、体外で酸素化した血液を再び動脈に注入することで、心臓と呼吸の両方をサポートします。VA ECMOは、心臓と肺の両方をバイパスすることで、これらの臓器に完全なサポートを提供するため、重症心不全や心停止の場合に使用されます。カニュレーションは通常、大腿動脈や頸動脈などの太い中心静脈から行われます。VA ECMOは主に呼吸補助に用いられ、血液は太い静脈から取り出され、ECMO回路を通して酸素化され、静脈に戻されます。このECMOモードは、急性呼吸窮迫症候群（ARDS）や肺炎などの病態によって肺が著しく損なわれている場合に、十分な酸素供給を確保します。VV ECMOの典型的なカニュレーション部位は、内頸静脈と大腿静脈です。

年齢：呼吸器疾患と心臓疾患による成人ECMO装置の必要性の増加

ECMO療法を必要とする成人患者は、従来の管理に反応しない重篤な呼吸器疾患や心臓疾患を患っています。これには、急性呼吸窮迫症候群（ARDS）、心原性ショック、肺塞栓症などの疾患が含まれます。成人用のECMO装置は、長時間の使用に耐える耐久性のある部品を使用して、より大きな血流を管理するように設計されています。新生児は、先天性横隔膜ヘルニアやメコン吸引症候群など、出生時の状態によりECMOサポートが必要となります。新生児ECMO装置は、新生児のデリケートで最小限の血液量を正確な制御と穏やかな流れで処理し、溶血やその他の血液関連合併症のリスクを最小限に抑えるように設計されています。新生児ECMO装置の主な特徴は、侵襲性を減らし、患者の体格に合わせて体外回路量を制限することに重点を置いていることです。新生児ECMO装置は、年長児や成人に使用されるものよりも小型のカニューレと特殊な回路を備えています。乳幼児から年長児までの小児患者は、標準的治療に反応しないさまざまな呼吸不全や心不全のためにECMOを必要とすることがあります。小児用ECMO装置は、このグループの患者の幅広い年齢と体格に対応できるよう、流速と酸素化器のサイズを調節できる汎用性が必要です。

コンポーネント：ECMO装置用の耐久性と生体適合性に優れた酸素供給器へのニーズの高まり

抗凝固システムはECMOのセットアップに不可欠であり、ECMO回路を通って体外に移動する血液が凝固するのを防ぐ。ECMO装置のブレンダーは、空気と純酸素を混合し、酸素濃度を制御して患者に供給します。ブレンダーは、患者のさまざまなニーズに対応するため、酸素濃度範囲を調節できるものでなければならないです。カニューレは、患者とECMO装置間の血流導管であり、特定の患者の解剖学的構造および外科的要件に合わせたさまざまなサイズと材質があります。熱交換器は、ECMO治療中の血液温度を調節し、患者の体温を維持するために重要です。モニタリングシステムは、患者のバイタルとECMO装置の性能を監視するために重要です。酸素供給器はECMO装置の心臓部であり、ここでガス交換が行われます。メーカーは現在、血液外傷を最小限に抑えながらガス交換効率を最大化する酸素供給器を製造しています。ポンプはECMO回路を通して血液を送り出すもので、ECMO装置では遠心ポンプとローラーポンプが2つの主要なポンプです。遠心ポンプは溶血率が低いため好まれ、ローラーポンプは簡便性と費用対効果で好まれます。

用途重要臓器への酸素血流を迅速に回復させるため、体外式心肺蘇生法（ECPR）の利用が増加しています。

ECMO装置は、重度の心不全患者やリスクの高い心臓手術中の生命維持の橋渡し役として、心臓用途に広く使用されています。このように使用される場合、ECMO装置が心臓の機能を代行し、血液に酸素を供給して全身循環を維持するため、患者の心臓は休息し、回復または修復する時間を得ることができます。これは、心臓がすぐに循環を維持できない可能性のある、心臓切開後の心原性ショックや心臓移植の際に特に重要です。体外心肺蘇生法（ECPR）は、心停止の場合、特に標準的な蘇生努力では自然循環が回復しない場合に、従来のCPRと並行してECMOを用いる新しい技術です。ECPRは、重要臓器への酸素血流を速やかに回復させることができるため、蘇生成功までの時間枠を延長し、長時間の酸素欠乏による神経障害のリスクを軽減することができます。ECMOは、一刻を争う介入が患者の生存に不可欠な心臓専門センターなど、迅速な展開が可能な環境において、貴重な選択肢となります。呼吸器への応用では、ECMOは、機械的人工呼吸を含む従来の管理に反応しない、重症で可逆的な呼吸不全に陥った患者に対する極めて重要な治療手段です。急性呼吸窮迫症候群（ARDS）、重症肺炎、肺塞栓症などの病態では、ECMOの使用が正当化されることがあります。ECMOシステムは、十分な酸素供給を行い二酸化炭素を除去することで、人工呼吸器による肺損傷を最小限に抑えながら、肺を休ませることができます。ECMOシステムは、新型インフルエンザやCOVID-19のような感染症の流行時を含め、重篤な呼吸器疾患の管理において極めて重要な役割を果たしています。

エンドユーザー：病院の集中治療室専用に対応する高度ECMO装置の開発

外来手術センター（ASC）は、診断や予防処置を含む外科治療を即日行う医療施設です。ASCでECMO装置が好まれるのは、複雑な手術中や術後間もないハイリスク患者に迅速な呼吸・心臓サポートを提供する必要性に基づいています。これには、短時間のECMOサポートしか必要としないと予想される患者や、長期の入院なしに迅速に対処できる特定のニーズを持つ患者が含まれます。病院は、ECMO装置が最もよく使用される集中治療室など、包括的でさまざまなレベルの患者ケアを提供するため、ECMO装置の主要なエンドユーザーとなっています。病院は主に、従来の人工呼吸や薬物療法では十分な効果が得られない、長時間の心臓・呼吸器サポートを必要とする患者にECMO装置を使用します。病院は一般に、ASCや専門クリニックよりも、複雑なECMO症例を管理するためのインフラや資源を豊富に有しています。専門クリニックは、特定のヘルスケア・サービスに特化した外来施設で、ECMO治療を行う場合もあります。専門クリニックでは、複雑だが安定した心臓または呼吸器疾患を有し、病院のような広範なリソースを必要としない患者を対象としたサポートを提供するために、ECMO装置を使用することがあります。このような環境でECMO装置が好まれるのは、治療への集中的なアプローチであり、特定のニーズを持つ患者に高度なケアを提供するためです。

地域別インサイト

南北アメリカ地域では、心血管系および呼吸器系疾患の高い罹患率、確立されたヘルスケアインフラストラクチャシステム、熟練した専門家の利用可能性により、体外式膜酸素供給装置が大きな成長を遂げています。さらに、この地域ではCOVID-19の大流行によりECMOの利用が急増し、市場の拡大にさらに拍車をかけています。研究開発への資金提供の増加と技術の進歩が相まって、ECMOシステムの機能が強化され、より効率的で使い勝手のよいクリティカルケアへの導入が進んでいます。EMEA地域のECMO装置市場は着実な成長を示しています。欧州では、医療費の増加、高齢化、生活習慣病の蔓延がECMOの需要に影響を与えています。主要国では、先進的な医療制度と医療機器導入に有利な政策により、ECMOの導入が進んでいます。アジア太平洋地域はECMO装置の高成長が見込まれています。経済開拓、ヘルスケア支出の増加、人口基盤の増加が市場成長を推進する極めて重要な力となっています。主要国はヘルスケア・インフラのアップグレードに多額の投資を行っています。さらに、一部の国では医療ツーリズム産業が活性化しており、ECMO機器市場に新たな道を開いています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、体外式膜酸素供給装置市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、体外式膜酸素供給装置市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.体外式膜酸素供給装置市場の市場規模および予測は？

2.体外式膜酸素供給装置市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.体外式膜酸素供給装置市場の技術動向と規制枠組みは？

4.体外式膜酸素供給装置市場における主要ベンダーの市場シェアは？

5.体外式膜酸素供給装置市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患および呼吸器疾患の有病率
    • 新生児ケアにおけるECMOの導入とECMOセンターの拡大
  • 抑制要因
    • ECMO装置の有害リコール
  • 機会
    • ECMO装置の継続的な進歩
    • 世界中でECMO機器の償還シナリオを改善
  • 課題
    • ECMOの操作とメンテナンスに伴う潜在的な複雑さ
• 市場セグメンテーション分析
  • 方法：心臓と呼吸の両方のサポートを提供する静脈動脈ECMOの利用が増加
  • 年齢：呼吸器疾患および心臓疾患により成人におけるECMO装置の必要性が増加
  • コンポーネント：ECMO装置用の耐久性と生体適合性を備えた酸素供給装置に対するニーズの高まり
  • 応用：体外心肺蘇生法（ECPR）は、重要な臓器への酸素化血流を迅速に回復させるため、その使用が急増しています。
  • エンドユーザー：病院の集中治療室専用機器に対応する高度なECMO装置の開発
• 市場動向分析
  • 南北アメリカ全域でヘルスケアインフラを確立し、専門的な調査活動に注力
  • アジア太平洋地域全体でヘルスケアインフラの改善に向けた投資が増加し、ECMO機器の導入が増加
  • EMEA地域でのECMOプログラムとトレーニングの拡大と相まって、有効性を評価するための調査活動が増加しています。
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 体外式膜酸素供給装置の市場：モダリティ別

• 動静脈ECMO
• 静脈動脈ECMO
• 静脈ECMO

第7章 体外式膜酸素供給装置の市場年齢別

• 成人用
• 新生児
• 小児科

第8章 体外式膜酸素供給装置の市場：コンポーネント別

• 抗凝固システム
• ブレンダー
• カニューレ
• 熱交換器
• 監視システム
• 酸素発生器
• ポンプ

第9章 体外式膜酸素供給装置の市場：用途別

• 心臓への応用
• 体外心肺蘇生
• 呼吸器への応用

第10章 体外式膜酸素供給装置の市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門クリニック

第11章 南北アメリカの体外式膜酸素供給装置の市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の体外式膜酸素供給装置の市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの体外式膜酸素供給装置の市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • ニューサウスウェールズ州政府（NSW）によるモバイル心臓治療に関する新たな革新的な臨床試験
  • インスピラ・テクノロジーズ、世界最大の体外生命維持カンファレンスで医療機器のINSPIRA ARTシリーズを発表
  • AIIMS-RがECMO治療を開始
  • MGMヘルスケア、小児向け先進的ECMOケア施設を開設
  • アボットの生命維持システムがFDAの新たな認可を取得し、医師がより多くの重篤な患者を治療できるよう支援
  • 国内初のECMO装置が重要な役割を果たす
  • 中国、重症COVID-19患者向けに自社開発のECMO装置を販売承認

第15章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET RESEARCH PROCESS
• FIGURE 2. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET DYNAMICS
• FIGURE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 20. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 26. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ARTERIOVENOUS ECMO, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ARTERIOVENOUS ECMO, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY NEONATE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY NEONATE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ANTICOAGULATION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ANTICOAGULATION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY BLENDER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY BLENDER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULAE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULAE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATOR, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATOR, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMP, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMP, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC APPLICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC APPLICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY APPLICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY APPLICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 59. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 60. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 61. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 62. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 63. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 64. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 65. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 66. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 67. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 68. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 69. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 70. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 71. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 72. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 73. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 74. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 75. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 76. ARGENTINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 77. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 78. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 79. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 80. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 81. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 82. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 83. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 84. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 85. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 86. BRAZIL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 87. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 88. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 89. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 90. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 91. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 92. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 93. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 96. CANADA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 97. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 98. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 99. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 100. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 101. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 102. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 103. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 104. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 105. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 106. MEXICO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 107. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 108. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 109. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 110. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 111. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 112. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 113. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 114. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 115. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 116. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 117. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 118. UNITED STATES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 120. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 122. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 124. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 126. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 127. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 128. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 130. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 131. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 132. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 133. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 134. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 135. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 136. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 137. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 138. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 139. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 140. AUSTRALIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 141. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 142. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 143. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 144. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 145. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 146. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 147. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 148. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 149. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 150. CHINA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 151. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 152. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 153. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 154. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 155. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 156. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 157. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 158. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 159. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 160. INDIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 161. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 162. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 163. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 164. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 165. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 166. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 167. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 168. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 169. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 170. INDONESIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 171. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 172. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 173. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 174. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 175. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 176. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 177. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 178. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 179. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 180. JAPAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 181. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 182. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 183. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 184. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 185. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 186. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 187. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 188. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 189. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 190. MALAYSIA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 191. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 192. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 193. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 194. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 195. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 196. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 197. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 198. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 199. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 200. PHILIPPINES EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 201. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 202. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 203. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 204. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 205. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 206. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 207. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 208. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 209. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 210. SINGAPORE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 211. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 212. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 213. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 214. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 215. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 216. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 217. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 218. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 219. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 220. SOUTH KOREA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 221. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 222. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 223. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 224. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 225. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 226. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 227. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 228. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 229. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 230. TAIWAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 231. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 232. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 233. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 234. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 235. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 236. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 237. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 238. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 239. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 240. THAILAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 241. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 242. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 243. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 244. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 245. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 246. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 247. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 248. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 249. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 250. VIETNAM EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 260. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 263. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 264. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 265. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 266. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 267. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 268. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 269. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 270. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 271. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 272. DENMARK EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 273. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2018-2023 (USD MILLION)
• TABLE 274. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2024-2030 (USD MILLION)
• TABLE 275. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2018-2023 (USD MILLION)
• TABLE 276. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AGE, 2024-2030 (USD MILLION)
• TABLE 277. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
• TABLE 278. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
• TABLE 279. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 280. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 281. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 282. EGYPT EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 283. FINLAND EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SI

[198 Pages Report] The Extracorporeal Membrane Oxygenation Machine Market size was estimated at USD 794.86 million in 2023 and expected to reach USD 832.14 million in 2024, at a CAGR 4.55% to reach USD 1,085.63 million by 2030.

Extracorporeal membrane oxygenation machines are medical devices that provide prolonged cardiac & respiratory support for patients whose hearts and lungs cannot provide adequate gas exchange to sustain life. These machines extract blood from the patient's body, oxygenate it through an artificial lung (the membrane), remove carbon dioxide, and then return it to the patient's bloodstream. This external life support system takes over the function of the heart and lungs, allowing these organs to rest and heal during critical illness. The surging prevalence of cardiovascular and respiratory diseases and technological advancements that improve patient outcomes have increased the adoption of ECMO systems. Additionally, improvements in healthcare infrastructure and increased healthcare spending are contributing to the market expansion. High costs associated with ECMO procedures and a limited number of trained healthcare professionals to operate these machines represent a challenge for market growth. Nevertheless, advancements in ECMO machine design to enhance portability and ease of use in different treatment settings are expected to provide opportunistic scope for the market. Moreover, ECMO integration with other extracorporeal therapies and research activities focused on expanding the indications for ECMO support is expected to boost the market.

Modality: Rising utilization of venoarterial ECMO as it provides both cardiac and respiratory support

Arteriovenous extracorporeal membrane oxygenation (AV ECMO) is an older method of ECMO support that utilizes the patient's arterial and venous blood flow to drive blood through the ECMO circuit. In AV ECMO, blood is drawn from an artery and returned to a vein after oxygenation. This technique relies on the patient's heart to pump blood through the oxygenator. It is less commonly used in modern ECMO therapy due to advancements in technology that prefer other modes for efficiency and safety. Venoarterial extracorporeal membrane oxygenation (VA ECMO) provides both cardiac and respiratory support by withdrawing venous blood, which is then oxygenated outside of the body and infused back into an artery. VA ECMO is used in cases of severe heart failure or cardiac arrest because it bypasses both the heart and the lungs, thus providing full support to these organs. The cannulation is usually done through the large central vessels, such as the femoral or carotid artery and vein. VA ECMO is utilized primarily for respiratory support, where blood is removed from a large vein, oxygenated through the ECMO circuit, and returned to a vein. This mode of ECMO ensures adequate oxygenation when the lungs are severely compromised by conditions including acute respiratory distress syndrome (ARDS) or pneumonia. The typical cannulation sites for VV ECMO include the internal jugular and femoral veins.

Age: Increasing need for ECMO machines in adults owing to respiratory & cardiac disorders

Adult patients who require ECMO therapy suffer from severe respiratory or cardiac conditions that are unresponsive to conventional management. These include conditions such as acute respiratory distress syndrome (ARDS), cardiogenic shock, or pulmonary embolism. Adult ECMO machines are designed to manage larger blood flow with durable components that can withstand extended use. Neonates require ECMO support due to conditions present at birth, such as congenital diaphragmatic hernia or meconium aspiration syndrome. Neonatal ECMO machines are designed to handle the delicate and minimal blood volume of newborns with precise control and gentle flow to minimize the risk of hemolysis or other blood-related complications. The primary distinction for neonatal ECMO machines is the focus on reducing invasiveness and limiting the extracorporeal circuit volume to suit the patient's size. The machines also have smaller cannulae and specialized circuits than those used for older children and adults. Pediatric patients, ranging from infants to older children, may require ECMO due to various respiratory and cardiac failures that are unresponsive to standard treatment. Pediatric ECMO machines must be versatile to accommodate the wide age and size range of patients in this group, with adjustability in flow rates and oxygenator sizes.

Component: Increasing need for durable and biocompatible oxygenators for ECMO machines

Anticoagulation systems are integral to the ECMO setup, preventing blood from clotting as it travels outside the body through the ECMO circuit. Blenders in ECMO machines mix air with pure oxygen, delivering controlled oxygen levels to the patient. Blenders must offer adjustable oxygen concentration ranges to cater to varying patient needs. Cannulae are conduits for blood flow between the patient and the ECMO machine, which come in various sizes and materials tailored to specific patient anatomy and surgical requirements. Heat exchangers regulate the blood temperature during ECMO therapy, crucial for maintaining the patient's core temperature. Monitoring systems are critical for overseeing the patient's vitals and the ECMO machine's performance. The oxygenator is the heart of the ECMO machine, where gas exchange occurs. Manufacturers are currently producing oxygenators that maximize gas exchange efficiency while minimizing blood trauma. The pump propels blood through the ECMO circuit, and centrifugal and roller pumps are the two primary pumps in ECMO machines. Centrifugal pumps are preferred for their lower hemolysis rates, while roller pumps are favored for their simplicity and cost-effectiveness.

Application: Proliferating usage of Extracorporeal Cardiopulmonary Resuscitation (ECPR) as it quickly restores oxygenated blood flow to vital organs

ECMO machines are widely used in cardiac applications as a life-supporting bridge for patients experiencing severe heart failure or during high-risk cardiac procedures. When used this way, the ECMO machine takes over the heart's function to oxygenate the blood and sustain systemic circulation, giving the patient's heart time to rest and recover or be repaired. This is particularly crucial during postcardiotomy cardiogenic shock or cardiac transplantation when the heart may not immediately sustain circulation. Extracorporeal Cardiopulmonary Resuscitation (ECPR) is an emerging technique where ECMO is employed alongside conventional CPR in cases of cardiac arrest, especially when the standard resuscitation efforts do not lead to a return of spontaneous circulation. ECPR can quickly restore oxygenated blood flow to vital organs, thus extending the timeframe for successful resuscitation and reducing the risk of neurological damage due to prolonged oxygen deprivation. It represents a valuable option in environments that facilitate rapid deployment, such as in specialized cardiac centers where time-sensitive interventions can be critical to patient survival. In respiratory applications, ECMO is a pivotal treatment modality for patients experiencing severe and potentially reversible respiratory failure that is not responsive to conventional management, including mechanical ventilation. Conditions including acute respiratory distress syndrome (ARDS), severe pneumonia, or pulmonary embolism may warrant the use of ECMO. The ECMO system allows the lungs to rest while minimizing ventilator-induced lung injury by providing adequate oxygenation and removing carbon dioxide. The ECMO system has played a pivotal role in managing critical respiratory conditions, including during outbreaks of infectious diseases such as the H1N1 influenza and COVID-19.

End-User: Development of advanced ECMO machines to cater to dedicated intensive care units in hospitals

Ambulatory surgical centers (ASCs) are healthcare facilities that provide same-day surgical care, including diagnostic and preventive procedures. The preference for ECMO machines in ASCs is based on the need to provide prompt respiratory or cardiac support for high-risk patients during complex surgeries or in the immediate postoperative period. This includes patients anticipated to require only a brief duration of ECMO support or those with specific needs that can be addressed rapidly without an extended hospital stay. Hospitals serve as the primary end-user segment for ECMO machines due to the comprehensive and varied levels of patient care they provide, including intensive care units where ECMO machines are most commonly utilized. Hospitals mainly use ECMO machines for patients requiring extended cardiac and respiratory support that cannot be adequately delivered through conventional ventilation or medication. Hospitals generally have greater infrastructure and resources to manage complex ECMO cases than ASCs or specialty clinics. Specialty clinics are outpatient facilities that focus on specific healthcare services, which may include providing ECMO treatment. Specialty clinics may employ ECMO machines to provide targeted support for patients with complex but stable cardiac or respiratory conditions that do not require the extensive resources of a hospital setting. The preference for ECMO machines in this setting is for a focused approach to treatment, offering advanced care to patients with specific needs.

Regional Insights

In the Americas region, extracorporeal membrane oxygenation machines have seen significant growth driven by the high incidence rates of cardiovascular and respiratory diseases, a well-established healthcare infrastructure system, and the availability of skilled professionals. Additionally, the region has seen a surge in ECMO utilization due to the COVID-19 pandemic, further fueling market expansion. Increased funding for research and development, coupled with technological advancements, continues to enhance ECMO system capabilities, making them more efficient and user-friendly for critical care adoption. The market landscape for ECMO machines in the EMEA region exhibits steady growth. In Europe, the demand for ECMO support is influenced by rising healthcare expenditures, an aging population, and the prevalence of lifestyle-associated diseases. Major economies are implementing ECMOs due to their advanced healthcare systems and policies that favor adopting medical devices. The Asia-Pacific region shows high-growth prospects for ECMO machines. Economic development, increasing healthcare expenditure, and a growing population base are pivotal forces propelling market growth. Major economies are investing heavily in upgrading their healthcare infrastructure. Moreover, the boosting medical tourism industry in some economies is also opening new avenues for the ECMO machines market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Extracorporeal Membrane Oxygenation Machine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Extracorporeal Membrane Oxygenation Machine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Extracorporeal Membrane Oxygenation Machine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abiomed, Inc., Baxter International Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corporation, Dragerwerk AG & Co. KGaA, Eurosets S.R.L., Getinge AB, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hengko Technology Co., Ltd., Inspira Technologies OXY B.H.N. Ltd., LivaNova PLC, MC3 Cardiopulmonary, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Origen Biomedical, Inc., Owgels Group, Senko Medical Instrument Mfg. Co., Ltd., Shenzhen Mindray Biomedical Electronics Co. Ltd., Technimount System, Terumo Corporation, XENIOS AG by Fresenius Medical Care AG & Co. KGaA, and ZOLL Medical Corporation by Asahi Kasei Corporation.

Market Segmentation & Coverage

This research report categorizes the Extracorporeal Membrane Oxygenation Machine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Modality
  • Arteriovenous ECMO
  • Venoarterial ECMO
  • Venovenous ECMO

• Age
  • Adult
  • Neonate
  • Pediatric

• Component
  • Anticoagulation Systems
  • Blender
  • Cannulae
  • Heat Exchanger
  • Monitoring Systems
  • Oxygenator
  • Pump

• Application
  • Cardiac Application
  • Extracorporeal Cardiopulmonary Resuscitation
  • Respiratory Application

• End-User
  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Extracorporeal Membrane Oxygenation Machine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Extracorporeal Membrane Oxygenation Machine Market?

3. What are the technology trends and regulatory frameworks in the Extracorporeal Membrane Oxygenation Machine Market?

4. What is the market share of the leading vendors in the Extracorporeal Membrane Oxygenation Machine Market?

5. Which modes and strategic moves are suitable for entering the Extracorporeal Membrane Oxygenation Machine Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of cardiovascular and respiratory diseases
    • 5.1.1.2. Adoption of ECMO for neonatal care and expansion of ECMO centers
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse recalls of ECMO machines
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in ECMO machines
    • 5.1.3.2. Improving reimbursement scenario for ECMO machines worldwide
  • 5.1.4. Challenges
    • 5.1.4.1. Potential complexity associated with the operation and maintenance of ECMO
• 5.2. Market Segmentation Analysis
  • 5.2.1. Modality: Rising utilization of venoarterial ECMO as it provides both cardiac and respiratory support
  • 5.2.2. Age: Increasing need for ECMO machines in adults owing to respiratory & cardiac disorders
  • 5.2.3. Component: Increasing need for durable and biocompatible oxygenators for ECMO machines
  • 5.2.4. Application: Proliferating usage of Extracorporeal Cardiopulmonary Resuscitation (ECPR) as it quickly restores oxygenated blood flow to vital organs
  • 5.2.5. End-User: Development of advanced ECMO machines to cater to dedicated intensive care units in hospitals
• 5.3. Market Trend Analysis
  • 5.3.1. Established healthcare infrastructure and focused on specialized research efforts across the Americas
  • 5.3.2. Increasing deployment of ECMO machines with rising investment for improving healthcare infrastructure across the APAC region
  • 5.3.3. Increasing research activities for evaluating effectiveness, coupled with growing ECMO programs and training in the EMEA region
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework Analysis

6. Extracorporeal Membrane Oxygenation Machine Market, by Modality

• 6.1. Introduction
• 6.2. Arteriovenous ECMO
• 6.3. Venoarterial ECMO
• 6.4. Venovenous ECMO

7. Extracorporeal Membrane Oxygenation Machine Market, by Age

• 7.1. Introduction
• 7.2. Adult
• 7.3. Neonate
• 7.4. Pediatric

8. Extracorporeal Membrane Oxygenation Machine Market, by Component

• 8.1. Introduction
• 8.2. Anticoagulation Systems
• 8.3. Blender
• 8.4. Cannulae
• 8.5. Heat Exchanger
• 8.6. Monitoring Systems
• 8.7. Oxygenator
• 8.8. Pump

9. Extracorporeal Membrane Oxygenation Machine Market, by Application

• 9.1. Introduction
• 9.2. Cardiac Application
• 9.3. Extracorporeal Cardiopulmonary Resuscitation
• 9.4. Respiratory Application

10. Extracorporeal Membrane Oxygenation Machine Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Specialty Clinics

11. Americas Extracorporeal Membrane Oxygenation Machine Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. The Government of New South Wales (NSW)'s New Innovative Clinical Trial with Mobile Cardiac Treatment
  • 14.3.2. Inspira Technologies Unveils the INSPIRA ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference
  • 14.3.3. AIIMS-R Starts ECMO Treatment
  • 14.3.4. MGM Healthcare Inaugurates Advanced ECMO Care Facility for Children
  • 14.3.5. Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients
  • 14.3.6. First Domestic ECMO Machine to Play Vital Role
  • 14.3.7. China Grants Market Approval to Self-Developed ECMO Device for Severe COVID-19 Cases

15. Competitive Portfolio

• 15.1. Key Company Profiles
• 15.2. Key Product Portfolio